A research group of IDIBELL and UB has revealed the importance of the function of NRF2, a protein that regulates the expression of some genes in response to oxidative radicals, in the maintenance of bone tissue.
Scientists discover an essential mechanism for maintaining bone density Read More »
The new program, following IDIBELL’s strategic plan, aims to promote interaction between both institutions and reinforce scientific collaboration.
The IDIBELL Neurometabolic Diseases team, which is also part of CIBERER, plans to start the study in early 2022 with the anti-inflammatory dimethyl fumarate in patients with this condition.
New clinical trial for adrenoleukodystrophy, a rare disease of brain metabolism Read More »
Under the title, “Re-definition of lung adenocarcinoma transcriptional subtypes using integrative bioinformatic approaches”, David Cordero, Ania Alay, Raúl Marín, Xavier Solé, and Ernest Nadal have collaborated in the work.
